A liquid biopsy is a blood test that more and more oncologists are using to help detect and treat lung cancer. Learn about the different types and what they do.

My mother has been diagnosed with breast cancer, and I’m helping with her medical appointments. Her oncologist says she needs ...

GeneCentric Therapeutics has earned an initial $8m in a Series C funding round, marking a step towards the launch and commercialisation of GenomicsNext, an integrated platform for comprehensive liquid ...

Liquid biopsy has significant potential in detecting various types of cancer at early stages, such as lung, breast, colorectal, prostate, and gastric cancers.

A new "liquid biopsy" test can help fast-track lung cancer patients to receive targeted therapy up to two weeks earlier, while helping some avoid further tests and treatments, including chemotherapy.

GeneCentric Therapeutics has secured $8m in new funding to accelerate the development of its RNA-based liquid biopsy platform, a diagnostic technology aimed at transforming cancer care through ...

“A liquid biopsy can give us a much broader overview.” Testing with a traditional tumor biopsy is a bit like studying an archaeological site by digging one small hole straight down into it. That’s a ...

NOGUCHI: Liquid biopsy is essentially a blood test that identifies fragments of DNA cast off by cancer cells in the body. ZHOU: Cancer is actually a genetic disease.

The liquid biopsy market size in cancer diagnostics is experiencing rapid growth due to advancements in non-invasive testing technologies. These tests, which analyze blood or other bodily fluids ...

The Glasgow, Scotland-based firm's Panaromic Platform uses an infrared spectroscopy-based test with machine learning-developed algorithms to detect signals of cancer.

Caris Life Sciences Inc., a health care company that uses technology to help diagnose and treat cancer, raised $494 million in a U.S. initial public ...